Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lisa M. Garrett"'
Autor:
Tetine Sentell PhD, Fiona Kennedy BSN, Todd Seto MD, MPH, May Vawer RN, Germán Chiriboga MPH, Coraleen Valdez APRN, Lisa M Garrett APRN-Rx, FNP-BC, Diane Paloma PhD, Deborah Taira ScD
Publikováno v:
Journal of Patient Experience, Vol 7 (2020)
Background: Native Hawaiians (NHs) suffer disproportionately from cardiovascular disease morbidity and mortality. Objective: To test a narrative intervention of patient stories to support heart disease self-management in NHs. Method: Six NH storytell
Externí odkaz:
https://doaj.org/article/1ca2fc0fb20345c09e331174082780b4
Autor:
Walter A. Blättler, Victor S. Goldmacher, Robert J. Lutz, Karen Hoffman, Lisa M. Garrett, Yelena V. Kovtun, Wayne C. Widdison, Peter U. Park, Hans K. Erickson
Supplementary Figures S1-S5 from Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563a7d6e238f33647ce10e7a69755818
https://doi.org/10.1158/0008-5472.22365749.v1
https://doi.org/10.1158/0008-5472.22365749.v1
Autor:
Walter A. Blättler, Victor S. Goldmacher, Robert J. Lutz, Karen Hoffman, Lisa M. Garrett, Yelena V. Kovtun, Wayne C. Widdison, Peter U. Park, Hans K. Erickson
Supplementary Figure Legends S1-S5 from Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148651bf8922c4cba523d2e4240ad41b
https://doi.org/10.1158/0008-5472.22365755
https://doi.org/10.1158/0008-5472.22365755
Autor:
Walter A. Blättler, Victor S. Goldmacher, Robert J. Lutz, Karen Hoffman, Lisa M. Garrett, Yelena V. Kovtun, Wayne C. Widdison, Peter U. Park, Hans K. Erickson
Antibody-drug conjugates are targeted anticancer agents consisting of a cytotoxic drug covalently linked to a monoclonal antibody for tumor antigen–specific activity. Once bound to the target cell-surface antigen, the conjugate must be processed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b699e419a52b321ba84a41935977d8b
https://doi.org/10.1158/0008-5472.c.6494843.v1
https://doi.org/10.1158/0008-5472.c.6494843.v1
Autor:
May Vawer, Fiona Kennedy, Tetine Sentell, Deborah A. Taira, Lisa M Garrett, Diane Paloma, Germán Chiriboga, Coraleen Valdez, Todd B. Seto
Publikováno v:
Journal of Patient Experience, Vol 7 (2020)
Journal of Patient Experience
Journal of Patient Experience
Background:Native Hawaiians (NHs) suffer disproportionately from cardiovascular disease morbidity and mortality.Objective:To test a narrative intervention of patient stories to support heart disease self-management in NHs.Method:Six NH storyteller vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4651132dcef2f915c5b328d46e6f46
https://doaj.org/article/1ca2fc0fb20345c09e331174082780b4
https://doaj.org/article/1ca2fc0fb20345c09e331174082780b4
Autor:
Brenda Kellogg, Gillian Payne, Rita Steeves, Michael L. Miller, Rajeeva Singh, Robert J. Lutz, Kathleen R. Whiteman, Barbara A. Leece, Katharine C. Lai, Ravi V. J. Chari, Hongsheng Xie, Wayne C. Widdison, John M. Lambert, Yelena Kovtun, Lisa M. Garrett
Publikováno v:
Bioconjugate chemistry. 22(4)
In this report, we describe the synthesis of a panel of disulfide-linked huC242 (anti-CanAg) antibody maytansinoid conjugates (AMCs), which have varying levels of steric hindrance around the disulfide bond, in order to investigate the relationship be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930866c19d726af85e377b30375a89c5
https://pubmed.ncbi.nlm.nih.gov/21425776
https://pubmed.ncbi.nlm.nih.gov/21425776
Autor:
Wayne C. Widdison, Walter A. Blattler, Hans K. Erickson, Yelena Kovtun, Robert J. Lutz, Victor S. Goldmacher, Lisa M. Garrett, Karen Hoffman, Peter U. Park
Publikováno v:
Cancer research. 66(8)
Antibody-drug conjugates are targeted anticancer agents consisting of a cytotoxic drug covalently linked to a monoclonal antibody for tumor antigen–specific activity. Once bound to the target cell-surface antigen, the conjugate must be processed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd8d5c885b4515c53c68007016eef15
https://pubmed.ncbi.nlm.nih.gov/27029797
https://pubmed.ncbi.nlm.nih.gov/27029797
Autor:
Erin K, Maloney, Jennifer L, McLaughlin, Nancy E, Dagdigian, Lisa M, Garrett, Katherine M, Connors, Xiao-Mai, Zhou, Walter A, Blättler, Thomas, Chittenden, Rajeeva, Singh
Publikováno v:
Cancer research. 63(16)
An antagonistic monoclonal antibody, designated EM164, has been developed which binds specifically to the human insulin-like growth factor I receptor (IGF-IR) and inhibits the proliferation and survival functions of the receptor in cancer cells. EM16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16e8cd07fbe9e85fdc56c448e73d658c
https://pubmed.ncbi.nlm.nih.gov/12941837
https://pubmed.ncbi.nlm.nih.gov/12941837